Article | September 17, 2024

WorldwideEdge™: Driving Innovation In Bioanalytical Lab Run Success Rates

Source: Worldwide Clinical Trials Lab Services
GettyImages-1016958284 biosimilar lab

At Worldwide Clinical Trials’ bioanalytical lab, challenges are seen as opportunities to drive excellence and innovation. Through the WorldwideEdge™ initiative, the lab continuously improves its processes and team performance to enhance drug development efficiency. Key improvements include adopting standardized tools for root cause analysis, fostering a culture of collaboration and ownership, and providing targeted educational support. These changes have significantly boosted lab efficiency and run success rates, consistently achieving a quality rate above 90% over seven months. By focusing on cross-functional teamwork and data-driven decision-making, Worldwide’s lab has set new standards in quality assurance and process optimization.

Learn more about WorldwideEdge™ by reading the full article below.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma

Worldwide Clinical Trials Lab Services